Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Hyperphagia

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Hyperphagia in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Hyperphagia: Ingestion of a greater than optimal quantity of food.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butruille, L1
Mayeur, S1
Duparc, T1
Knauf, C1
Moitrot, E1
Fajardy, I1
Valet, P1
Storme, L1
Deruelle, P1
Lesage, J1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Hyperphagia

ArticleYear
Prenatal fasudil exposure alleviates fetal growth but programs hyperphagia and overweight in the adult male rat.
    European journal of pharmacology, 2012, Aug-15, Volume: 689, Issue:1-3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Age Factors; Animals; Female; Fetal Development; Feta

2012